LoPriore Vincent S — SEC insider filings
SEC reporting owner CIK 1633927. 6 insider filings on record with FilingPulse; latest filed 2026-10-27.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2025-11-05 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 16,250,000 shares, $750,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 8,000,000 shares @ $0.05 ($400,000) in Hepion Pharmaceuticals, Inc., filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | Executive Chairman, Director | 5 | 4 legs · 16,250,000 sh · $750,000 | — | 5 |
| Tharimmune, Inc. (THAR) | Executive Chairman, Director, 10% owner | 1 | — | — | 1 |
Insider filings — LoPriore Vincent S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-27 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/award (A): 1,530,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 12,500,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 8,000,000 @ $0.05 · Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 8,000,000 (derivative) @ $0 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 5,000,000 @ $0.04 · Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2025-11-05 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-11-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1633927 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs